Samira Anbari

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Systematic Review

Replacement Therapy

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Top Venues

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Hanwen Wang, Theinmozhi Arulraj, Samira Anbari, Aleksander S Popel
Quantitative systems pharmacology modeling of macrophage-targeted therapy combined with PD-L1 inhibition in advanced NSCLC. Clinical and translational science 17 (6) (2024)
Hanwen Wang, Theinmozhi Arulraj, Samira Anbari, Aleksander S Popel
Quantitative systems pharmacology modeling of macrophage-targeted therapy combined with PD-L1 inhibition in advanced NSCLC. Clinical and translational science 17 (6) (2024)
Hanwen Wang, Theinmozhi Arulraj, Samira Anbari, Aleksander S Popel
Quantitative systems pharmacology modeling of macrophage-targeted therapy combined with PD-L1 inhibition in advanced NSCLC. Clinical and translational science 17 (6) (2024)